Page last updated: 2024-11-06

prednisolone and Esophageal Neoplasms

prednisolone has been researched along with Esophageal Neoplasms in 28 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the effectiveness of oral prednisolone in controlling postprocedure esophageal stricture."7.77Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Nishiyama, H; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011)
"Oral prednisolone was started with 0."5.37Effect of oral prednisolone on esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a case report. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011)
" Those who received intralesional triamcinolone injection combined with oral prednisolone administration were assigned to the treatment group, while those who were treated without any prophylaxis of esophageal stricture were assigned to the control group."3.91Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms. ( Chen, T; Chen, W; Chu, Y; Li, H; Xu, M; Yao, L; Zhang, Y; Zhong, Y; Zhou, P, 2019)
"To evaluate the effectiveness of oral prednisolone in controlling postprocedure esophageal stricture."3.77Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Nishiyama, H; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011)
"Use of oral prednisolone administration may be an effective treatment strategy for reducing post-ESD esophageal stricture after complete circular ESD."3.77Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Nishiyama, H; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011)
"Dermatomyositis is a multisystem disease manifesting as an idiopathic inflammatory myopathy, characterised predominantly by cutaneous and muscular abnormalities."1.48Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer. ( Laidler, NK, 2018)
"Oral prednisolone was administered to the study group at a dose of 30 mg/day on the third day post-ESD, and then tapered gradually (30, 25, 20, 15, 10, and 5 mg for 14 days)."1.46Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. ( Cai, J; Gong, W; Su, L; Tang, X; Yuan, F; Zhang, Y; Zhou, G, 2017)
"There has been no recurrence of esophageal cancer or relapse of nephrotic syndrome during a period of 18 months after esophagectomy."1.39Patient with esophageal cancer showing remission of nephrotic syndrome after esophagectomy: report of a case. ( Iida, M; Ito, H; Kawano, T; Kumagai, Y; Odajima, H; Yamazaki, S, 2013)
"We describe a patient with inoperable oesophageal cancer who had unexplained mental confusion for three days due to an unobserved corticosteroid-induced hyperglycaemic hyperosmolar syndrome."1.39[In-hospital cardiac arrest due to unobserved steroid-induced hyperglycaemic hyperosmolar syndrome]. ( Brandt, B; Jensen, K; Steinthorsdottir, KJ, 2013)
"We report a case of acquired hemophilia A (AHA) after esophageal resection."1.39Acquired hemophilia A caused by factor VIII inhibitors: report of a case. ( Hosoya, Y; Lefor, A; Madoiwa, S; Matsumoto, S; Matsumura, M; Nunomiya, S; Sata, N; Yasuda, Y; Zuiki, T, 2013)
"Medical history revealed dysphagia during the past 6 months and further evaluation brought to light a squamous cell carcinoma (SCC) in the esophagus."1.39Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma. ( Ahmadinejad, M; Minoo, A; Nader, R; Roushan, N, 2013)
"Oral prednisolone was started with 0."1.37Effect of oral prednisolone on esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a case report. ( Hayashi, T; Isomoto, H; Kohno, S; Nakao, K; Nakayama, T; Ohnita, K; Shikuwa, S; Takeshima, F; Yamaguchi, N, 2011)
"Endoscopic examination revealed esophageal cancer."1.29[Chronic myelomonocytic leukemia and esophageal cancer developed in a renal allograft recipient]. ( Fujita, N; Goto, H; Inaba, T; Itoh, K; Misawa, S; Murakami, S; Nakagawa, M; Oku, N; Shima, T; Shimazaki, C, 1993)
"Prednisolone could cause dramatic increase in activity of ALP, but no change in ALP isozyme spectrum and concomitant increase in lactic dehydrogenase activity were found after prednisolone treatment."1.29[Expression of placental alkaline phosphatase in esophageal cancer cell line Eca109]. ( Yan, X; Zhang, F; Zhang, M, 1996)
"Domperidone was given twice a day for one week."1.27[Effect of combined use of adrenocortical hormones and domperidone as anti-emetics during cisplatin therapy]. ( Hirose, Y; Matsushita, T; Mise, K; Nakanishi, M; Shirosaki, H; Tanaka, T; Yamaoto, T, 1985)

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19902 (7.14)18.7374
1990's4 (14.29)18.2507
2000's2 (7.14)29.6817
2010's18 (64.29)24.3611
2020's2 (7.14)2.80

Authors

AuthorsStudies
Kaviani, A1
Khansari Nejad, N1
Akour, A1
AlMuhaissen, SA1
Nusair, MB1
Al-Tammemi, AB1
Mahmoud, NN1
Jalouqa, S1
Alrawashdeh, MN1
Shanahan, JP1
Moore, CM1
Kampf, JW1
Szymczak, NK1
Guo, J1
Wang, H1
Luo, Y1
An, H1
Zhang, Z2
Liu, G1
Li, J1
Metcalfe, GD1
Smith, TW1
Hippler, M1
Ayala Izurieta, JE1
Márquez, CO1
García, VJ1
Jara Santillán, CA1
Sisti, JM1
Pasqualotto, N1
Van Wittenberghe, S1
Delegido, J1
Kubo, Y1
Kitagawa, Y1
Miyazaki, T1
Sohda, M1
Yamaji, T1
Sakai, M1
Saeki, H1
Nemoto, K1
Oyama, T2
Muto, M1
Takeuchi, H1
Toh, Y1
Matsubara, H1
Mano, M1
Kono, K1
Kato, K1
Yoshida, M1
Kawakubo, H1
Booka, E1
Yamatsuji, T1
Kato, H1
Ito, Y1
Ishikawa, H1
Ishihara, R1
Tsushima, T1
Kawachi, H1
Kojima, T1
Kuribayashi, S1
Makino, T1
Matsuda, S1
Doki, Y1
Ma, P1
Tang, X2
Zhang, L2
Wang, X1
Wang, W1
Zhang, X1
Wang, S2
Zhou, N1
Dodd, J1
Jordan, R1
Makhlina, M1
Pesco Koplowitz, L1
Koplowitz, B1
Barnett, K1
Yang, WH1
Spana, C1
Buchanan, SW1
Mafa-Attoye, T1
Dunfield, K1
Thevathasan, NV1
Isaac, ME1
Wu, X2
Huang, JW1
Su, BK1
Yuan, L1
Zheng, WQ1
Zhang, H2
Zheng, YX1
Zhu, W1
Chou, PT1
Manso, AP1
De Morais, DC1
Yamamoto, K1
Owen, G1
de Carvalho, RM1
Palma-Dibb, RG1
Brown, JC1
Yang, S1
Mire, EF1
Miele, L1
Ochoa, A1
Zabaleta, J1
Katzmarzyk, PT1
Moi, CT1
Bhowmick, S1
Qureshi, M1
Wang, K1
Feng, B1
Yang, Y1
Chen, Y1
Wang, Y2
Yang, L1
Jiang, K1
James, TD1
Chaturvedi, V1
Postiglione, WM1
Chakraborty, RD1
Yu, B1
Tabiś, W1
Hameed, S1
Biniskos, N1
Jacobson, A1
Zhou, H1
Greven, M1
Ferry, VE1
Leighton, C1
Wu, F1
Lei, H1
Chen, G1
Chen, C1
Song, Y1
Cao, Z1
Zhang, C2
Zhou, J1
Lu, Y1
Pappone, C1
Santinelli, V1
Mecarocci, V1
Tondi, L1
Ciconte, G1
Manguso, F1
Sturla, F1
Vicedomini, G1
Micaglio, E1
Anastasia, L1
Pica, S1
Camporeale, A1
Lombardi, M1
Shieh, PB1
Elfring, G1
Trifillis, P1
Santos, C1
Peltz, SW1
Parsons, JA1
Apkon, S1
Darras, BT1
Campbell, C1
McDonald, CM1
Galaviz, KI1
Shah, NS1
Gutierrez, M1
Collins, LF1
Lahiri, CD1
Moran, CA1
Szabo, B1
Sumitani, J1
Rhodes, J1
Marconi, VC1
Nguyen, ML1
Cantos, VD1
Armstrong, WS1
Colasanti, JA1
Kadota, T1
Yoda, Y1
Hori, K1
Shinmura, K1
Oono, Y1
Ikematsu, H1
Yano, T1
Zhou, G1
Yuan, F1
Cai, J1
Gong, W1
Su, L1
Zhang, Y2
Iizuka, T1
Kikuchi, D1
Hoteya, S1
Kaise, M1
Chu, Y1
Chen, T1
Li, H1
Zhou, P1
Chen, W1
Zhong, Y1
Yao, L1
Xu, M1
Laidler, NK1
Sato, H1
Inoue, H1
Kobayashi, Y1
Maselli, R1
Santi, EG1
Hayee, B1
Igarashi, K1
Yoshida, A1
Ikeda, H1
Onimaru, M1
Aoyagi, Y1
Kudo, SE1
Ito, H1
Kumagai, Y1
Iida, M1
Yamazaki, S1
Odajima, H1
Kawano, T1
Jensen, K1
Steinthorsdottir, KJ1
Brandt, B1
Ishida, T1
Morita, Y1
Hoshi, N1
Yoshizaki, T1
Ohara, Y1
Kawara, F1
Tanaka, S1
Yamamoto, Y1
Matsuo, H1
Iwata, K1
Toyonaga, T1
Azuma, T1
Ito, M1
Matsumoto, S2
Takayama, T1
Wakatsuki, K1
Tanaka, T2
Migita, K1
Nakajima, Y1
Yu, JP1
Liu, YJ1
Tao, YL1
Ruan, RW1
Cui, Z1
Zhu, SW1
Shi, W1
Mihara, K1
Sasaki, N1
Mamoru, O1
Kanbe, M1
Ichinohe, T1
Suehiro, S1
Nakashima, H1
Fujimoto, M1
Watanabe, R1
Ishiura, N1
Yamamoto, AI1
Hashimoto, T1
Tamaki, K1
Yamaguchi, N3
Isomoto, H3
Shikuwa, S3
Nakayama, T3
Hayashi, T3
Ohnita, K3
Takeshima, F3
Kohno, S3
Nakao, K3
Nishiyama, H2
Sawada, T1
Adachi, Y1
Ishii, Y1
Yasui, H1
Arimura, Y1
Endo, T1
Hosoya, Y1
Matsumura, M1
Madoiwa, S1
Zuiki, T1
Nunomiya, S1
Lefor, A1
Sata, N1
Yasuda, Y1
Ahmadinejad, M1
Minoo, A1
Roushan, N1
Nader, R1
Shibuya, Y1
Matuo, K1
Kawada, T1
Kosugi, T1
Gomi, T1
Takahashi, O1
Okushiba, S1
Kondo, S1
Morikawa, T1
Hirano, S1
Miyamoto, M1
Shichinohe, T1
Hara, T1
Kawarada, Y1
Saito, K1
Takeuchi, M1
Shima, T1
Oku, N1
Goto, H1
Inaba, T1
Murakami, S1
Itoh, K1
Fujita, N1
Shimazaki, C1
Misawa, S1
Nakagawa, M1
Gupta, NM1
Goenka, MK1
Jindal, A1
Behera, A1
Vaiphei, K1
Ramesh, V1
Tanwar, RK1
Kaushal, R1
Rath, GK1
Vaid, A1
Pathak, V1
Choubey, RP1
Zhang, M1
Yan, X1
Zhang, F1
Beĭbutov, ShM1
Isaev, IG1
Nakanishi, M1
Hirose, Y1
Mise, K1
Matsushita, T1
Yamaoto, T1
Shirosaki, H1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Administration of Oral Prednisolone to Prevent Esophageal Stricture After Balloon-type Radiofrequency Ablation for Long-segment Esophageal Neoplasia[NCT05768282]Phase 450 participants (Anticipated)Interventional2016-01-01Recruiting
Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery[NCT02703376]Phase 18 participants (Anticipated)Interventional2016-01-31Recruiting
Effectiveness Evaluation of Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Early Esophageal Cancer Invading More Than 2/3 Esophageal Perimeter[NCT03165344]66 participants (Actual)Interventional2017-02-10Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for prednisolone and Esophageal Neoplasms

ArticleYear
    Biomaterial investigations in dentistry, 2021, Volume: 8, Issue:1

    Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes

2021
Cronkhite-Canada syndrome associated with esophageal and gastric cancers: report of a case.
    Surgery today, 2015, Volume: 45, Issue:6

    Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Endoscopy, Gastrointestinal; Esop

2015
Prevention of Esophageal Stricture After Endoscopic Submucosal Dissection: A Systematic Review.
    World journal of surgery, 2015, Volume: 39, Issue:12

    Topics: Administration, Oral; Anti-Inflammatory Agents; Dilatation; Dissection; Esophageal Neoplasms; Esopha

2015
[Adult onset Still's disease associated esophageal cancer: a case report].
    Ryumachi. [Rheumatism], 2003, Volume: 43, Issue:3

    Topics: Aged; Anti-Inflammatory Agents; Esophageal Neoplasms; Humans; Male; Paraneoplastic Syndromes; Predni

2003
Primary lymphoma of the esophagus.
    Journal of clinical gastroenterology, 1996, Volume: 23, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Ad

1996

Other Studies

23 other studies available for prednisolone and Esophageal Neoplasms

ArticleYear
Prophylactic steroid administration against strictures is not enough for mucosal defects involving the entire circumference of the esophageal lumen after esophageal endoscopic submucosal dissection (ESD).
    Esophagus : official journal of the Japan Esophageal Society, 2020, Volume: 17, Issue:4

    Topics: Aged; Aged, 80 and over; Catheterization; Constriction, Pathologic; Dilatation; Endoscopic Mucosal R

2020
Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Thoracic cancer, 2017, Volume: 8, Issue:5

    Topics: Administration, Oral; Aged; Carcinoma, Squamous Cell; Drug Administration Schedule; Endoscopic Mucos

2017
Effectiveness of modified oral steroid administration for preventing esophageal stricture after entire circumferential endoscopic submucosal dissection.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2018, Jul-01, Volume: 31, Issue:7

    Topics: Administration, Oral; Aged; Aged, 80 and over; Endoscopic Mucosal Resection; Esophageal Neoplasms; E

2018
Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms.
    Surgical endoscopy, 2019, Volume: 33, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma; Dilatation; Endoscopic Mucosal Resection;

2019
Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer.
    BMJ case reports, 2018, Dec-07, Volume: 11, Issue:1

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Dermatomyositis; Endoscopic Mucosal Resection

2018
Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone.
    Gastrointestinal endoscopy, 2013, Volume: 78, Issue:2

    Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Squamous Cell; Cohort Studies; Combined Modal

2013
Patient with esophageal cancer showing remission of nephrotic syndrome after esophagectomy: report of a case.
    Surgery today, 2013, Volume: 43, Issue:12

    Topics: Aged; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Esophageal Neoplasms; Esoph

2013
[In-hospital cardiac arrest due to unobserved steroid-induced hyperglycaemic hyperosmolar syndrome].
    Ugeskrift for laeger, 2013, Apr-08, Volume: 175, Issue:15

    Topics: Diagnostic Errors; Esophageal Neoplasms; Female; Glucocorticoids; Heart Arrest; Humans; Hyperglycemi

2013
Disseminated nocardiosis during systemic steroid therapy for the prevention of esophageal stricture after endoscopic submucosal dissection.
    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2015, Volume: 27, Issue:3

    Topics: Administration, Oral; Aged, 80 and over; Bacteremia; Dissection; Dose-Response Relationship, Drug; D

2015
Solitary plasmablastic lymphoma in the esophagus.
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Esophageal Neo

2016
Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
    The Journal of dermatology, 2010, Volume: 37, Issue:3

    Topics: Aged; Autoantibodies; Carcinoma, Squamous Cell; Dapsone; Desmoglein 1; Desmoglein 3; Desmosomes; Eos

2010
Effect of oral prednisolone on esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a case report.
    Digestion, 2011, Volume: 83, Issue:4

    Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Dissection; Endoscopy, Gastrointestinal;

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Gastrointestinal endoscopy, 2011, Volume: 73, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Deglut

2011
Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    BMC gastroenterology, 2011, May-04, Volume: 11

    Topics: Aged; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Catheterization; Dissection; Esophageal Ne

2011
Esophageal lesions in myeloproliferative neoplasms.
    Endoscopy, 2012, Volume: 44 Suppl 2 UCTN

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Esophageal Neopl

2012
Acquired hemophilia A caused by factor VIII inhibitors: report of a case.
    Surgery today, 2013, Volume: 43, Issue:6

    Topics: Aged, 80 and over; Autoantibodies; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Esophage

2013
Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:1

    Topics: Adrenal Cortex Hormones; Aged, 80 and over; Autoantibodies; Autoimmune Diseases; Carcinoma, Squamous

2013
Esophageal pemphigus vulgaris with carcinoma: postoperative steroid therapy based on pemphigus-related antibodies.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2005, Volume: 18, Issue:6

    Topics: Aged; Autoantibodies; Carcinoma, Squamous Cell; Desmogleins; Esophageal Neoplasms; Esophagectomy; Hu

2005
[Chronic myelomonocytic leukemia and esophageal cancer developed in a renal allograft recipient].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:7

    Topics: Azathioprine; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Immunosuppression Therapy; Kid

1993
Synchronous oesophageal carcinoma with non Hodgkin's lymphoma, problems with management.
    Indian journal of cancer, 1996, Volume: 33, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy;

1996
[Expression of placental alkaline phosphatase in esophageal cancer cell line Eca109].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1996, Volume: 18, Issue:3

    Topics: Alkaline Phosphatase; Antineoplastic Agents, Hormonal; Esophageal Neoplasms; GPI-Linked Proteins; Hu

1996
[Immediate results of polychemotherapy in esophageal cancer patients].
    Terapevticheskii arkhiv, 1986, Volume: 58, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Demecolcine; Drug Evaluation

1986
[Effect of combined use of adrenocortical hormones and domperidone as anti-emetics during cisplatin therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Cisplatin; Domperidone; Drug Therapy, Combination; Esophageal Neoplas

1985